$Gemcitabine in the Treatment of Refractory Hodgkin’s Disease: Results of a Multicenter Phase II Study$

Gemcitabine in the Treatment of Refractory Hodgkin’s Disease: Results of a Multicenter Phase II Study

Santoro, A.; Bredenfeld, H.; Devizzi, L.; Tesch, H.; Bonfante, V.; Viviani, S.; Fiedler, F.; Parra, H. Soto; Benoehr, C.; Pacini, M.; Bonadonna, G.; Diehl, V.

期刊名称Journal of Clinical Oncology
作者Santoro, A.; Bredenfeld, H.; Devizzi, L.; Tesch, H.; Bonfante, V.; Viviani, S.; Fiedler, F.; Parra, H. Soto; Benoehr, C.; Pacini, M.; Bonadonna, G.; Diehl, V.
卷第18卷
期第13期
印刷ISSN0732-183X
电子ISSN1527-7755
文件大小45.50KB
发表时间2000-07
DOI10.1200/JCO.2000.18.13.2615
页码2615-2619

发现好书期刊，享受阅读乐趣

Gemcitabine in the Treatment of Refractory Hodgkin’s Disease: Results of a Multicenter Phase II Study